Is Core Laboratories Stock a Good Investment?
Core Laboratories Investment Advice | CLB |
- Examine Core Laboratories' financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Core Laboratories' leadership team and their track record. Good management can help Core Laboratories navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Oil & Gas Equipment & Services space and any emerging trends that could impact Core Laboratories' business and its evolving consumer preferences.
- Compare Core Laboratories' performance and market position to its competitors. Analyze how Core Laboratories is positioned in terms of product offerings, innovation, and market share.
- Check if Core Laboratories pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Core Laboratories' stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Core Laboratories NV stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Core Laboratories NV is a good investment.
Sell | Buy |
Cautious Hold
Market Performance | Weak | Details | |
Volatility | Very steady | Details | |
Hype Condition | Low key | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Very Small | Details | |
Economic Sensitivity | Almost mirrors the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Hold | Details | |
Financial Strenth (F Score) | Strong | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Possible Manipulator | Details |
Examine Core Laboratories Stock
Researching Core Laboratories' stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 99.0% of the company shares are held by institutions such as insurance companies. The book value of Core Laboratories was currently reported as 4.98. The company has Price/Earnings To Growth (PEG) ratio of 2.15. Core Laboratories last dividend was issued on the 3rd of May 2024. The entity had 2:1 split on the 9th of July 2010.
To determine if Core Laboratories is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Core Laboratories' research are outlined below:
| Core Laboratories is unlikely to experience financial distress in the next 2 years | |
| Core Laboratories has a strong financial position based on the latest SEC filings | |
| Over 99.0% of the company shares are held by institutions such as insurance companies | |
| On 4th of March 2024 Core Laboratories paid $ 0.01 per share dividend to its current shareholders | |
| Latest headline from simplywall.st: Core Laboratories First Quarter 2024 Earnings Revenues Beat Expectations, EPS Lags |
Core Laboratories Quarterly Accounts Payable |
|
Core Laboratories uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Core Laboratories NV. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Core Laboratories' previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 31st of January 2024 Upcoming Quarterly Report | View | |
| 24th of April 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 31st of January 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Earnings surprises can significantly impact Core Laboratories' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Core Laboratories' investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2022-04-27 | 2022-03-31 | 0.09 | 0.08 | -0.01 | 11 | ||
2003-05-09 | 2003-03-31 | 0.05 | 0.04 | -0.01 | 20 | ||
2002-05-07 | 2002-03-31 | 0.06 | 0.05 | -0.01 | 16 | ||
2000-07-28 | 2000-06-30 | 0.06 | 0.07 | 0.01 | 16 | ||
2000-04-28 | 2000-03-31 | 0.06 | 0.05 | -0.01 | 16 | ||
1999-04-30 | 1999-03-31 | 0.01 | 0.02 | 0.01 | 100 | ||
1998-04-23 | 1998-03-31 | 0.08 | 0.09 | 0.01 | 12 | ||
1997-08-14 | 1997-06-30 | 0.07 | 0.08 | 0.01 | 14 |
Core Laboratories Target Price Consensus
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Core target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Core Laboratories' target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 9 | Hold |
Most Core analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Core stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Core Laboratories, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationCore Laboratories Target Price Projection
Core Laboratories' current and average target prices are 16.94 and 23.25, respectively. The current price of Core Laboratories is the price at which Core Laboratories NV is currently trading. On the other hand, Core Laboratories' target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Core Laboratories Market Quote on 28th of April 2024
Target Price
Analyst Consensus On Core Laboratories Target Price
Core Laboratories Analyst Ratings
Core Laboratories' analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Core Laboratories stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Core Laboratories' financials, market performance, and future outlook by experienced professionals. Core Laboratories' historical ratings below, therefore, can serve as a valuable tool for investors.Know Core Laboratories' Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Core Laboratories is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Core Laboratories NV backward and forwards among themselves. Core Laboratories' institutional investor refers to the entity that pools money to purchase Core Laboratories' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Royce & Associates, Lp | 2023-12-31 | 914.3 K | Fisher Asset Management, Llc | 2023-12-31 | 754.4 K | Disciplined Growth Investors Inc | 2023-12-31 | 752.4 K | Morgan Stanley - Brokerage Accounts | 2023-12-31 | 727.5 K | Van Eck Associates Corporation | 2023-12-31 | 586.4 K | Charles Schwab Investment Management Inc | 2023-12-31 | 580.4 K | Northern Trust Corp | 2023-12-31 | 494.3 K | Bank Of New York Mellon Corp | 2023-12-31 | 464 K | Amvescap Plc. | 2023-12-31 | 412.5 K | Ariel Investments, Llc | 2023-12-31 | 9 M | Blackrock Inc | 2023-12-31 | 8 M |
Core Laboratories' market capitalization trends
The company currently falls under 'Small-Cap' category with a total capitalization of 790.49 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Core Laboratories's market, we take the total number of its shares issued and multiply it by Core Laboratories's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Market Cap |
|
Core Laboratories' profitablity analysis
Core Laboratories' profitability indicators refer to fundamental financial ratios that showcase Core Laboratories' ability to generate income relative to its revenue or operating costs. If, let's say, Core Laboratories is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Core Laboratories' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Core Laboratories' profitability requires more research than a typical breakdown of Core Laboratories' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.08 | 0.15 | |
| Return On Capital Employed | 0.11 | 0.21 | |
| Return On Assets | 0.06 | 0.10 | |
| Return On Equity | 0.16 | 0.32 |
Determining Core Laboratories' profitability involves analyzing its financial statements and using various financial metrics to determine if Core Laboratories is a good buy. For example, gross profit margin measures Core Laboratories' profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Core Laboratories' profitability and make more informed investment decisions.
The data published in Core Laboratories' official financial statements usually reflect Core Laboratories' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Core Laboratories. For example, before you start analyzing numbers published by Core accountants, it's critical to develop an understanding of what Core Laboratories' liquidity, profitability, and earnings quality are in the context of the Energy Equipment & Services space in which it operates.
Please note, the presentation of Core Laboratories' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Core Laboratories' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Core Laboratories' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Core Laboratories NV. Please utilize our Beneish M Score to check the likelihood of Core Laboratories' management manipulating its earnings.
Evaluate Core Laboratories' management efficiency
Core Laboratories has Return on Asset of 0.0618 % which means that on every $100 spent on assets, it made $0.0618 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.174 %, implying that it generated $0.174 on every 100 dollars invested. Core Laboratories' management efficiency ratios could be used to measure how well Core Laboratories manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Tangible Assets is expected to grow to 0.15. The current year's Return On Capital Employed is expected to grow to 0.21. At present, Core Laboratories' Non Currrent Assets Other are projected to decrease significantly based on the last few years of reporting. The current year's Other Current Assets is expected to grow to about 26 M, whereas Total Assets are forecasted to decline to about 550.2 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 4.82 | 2.62 | |
| Net Current Asset Value | 0.00 | 0.00 | |
| Tangible Asset Value | 0.00 | 0.00 | |
| Tangible Book Value Per Share | 2.64 | 2.78 | |
| Enterprise Value Over EBITDA | 14.73 | 14.28 | |
| Price Book Value Ratio | 3.67 | 6.42 | |
| Enterprise Value Multiple | 14.73 | 14.28 | |
| Price Fair Value | 3.67 | 6.42 | |
| Enterprise Value | 4.5 B | 2.7 B |
The analysis of Core Laboratories' management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze Core Laboratories' future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of Core Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Dividend Yield 0.0024 | Forward Dividend Yield 0.0024 | Forward Dividend Rate 0.04 | Beta 2.426 |
Basic technical analysis of Core Stock
As of the 28th of April, Core Laboratories shows the Mean Deviation of 1.69, downside deviation of 2.3, and Risk Adjusted Performance of 0.0319. Core Laboratories technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to break down and interpolate nineteen technical drivers for Core Laboratories NV, which can be compared to its peers. Please confirm Core Laboratories value at risk, expected short fall, and the relationship between the treynor ratio and downside variance to decide if Core Laboratories is priced correctly, providing market reflects its regular price of 16.94 per share. Given that Core Laboratories has jensen alpha of (0.01), we suggest you to validate Core Laboratories NV's prevailing market performance to make sure the company can sustain itself at a future point.Core Laboratories' insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Core Laboratories insiders, such as employees or executives, is commonly permitted as long as it does not rely on Core Laboratories' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Core Laboratories insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Understand Core Laboratories' technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Core Laboratories' various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.0319 | |||
| Market Risk Adjusted Performance | 0.0806 | |||
| Mean Deviation | 1.69 | |||
| Semi Deviation | 2.2 | |||
| Downside Deviation | 2.3 | |||
| Coefficient Of Variation | 2516.77 | |||
| Standard Deviation | 2.17 | |||
| Variance | 4.71 | |||
| Information Ratio | (0) | |||
| Jensen Alpha | (0.01) | |||
| Total Risk Alpha | (0.20) | |||
| Sortino Ratio | (0) | |||
| Treynor Ratio | 0.0706 | |||
| Maximum Drawdown | 9.67 | |||
| Value At Risk | (3.61) | |||
| Potential Upside | 3.27 | |||
| Downside Variance | 5.29 | |||
| Semi Variance | 4.85 | |||
| Expected Short fall | (1.63) | |||
| Skewness | (0.07) | |||
| Kurtosis | 0.1841 |
| Risk Adjusted Performance | 0.0319 | |||
| Market Risk Adjusted Performance | 0.0806 | |||
| Mean Deviation | 1.69 | |||
| Semi Deviation | 2.2 | |||
| Downside Deviation | 2.3 | |||
| Coefficient Of Variation | 2516.77 | |||
| Standard Deviation | 2.17 | |||
| Variance | 4.71 | |||
| Information Ratio | (0) | |||
| Jensen Alpha | (0.01) | |||
| Total Risk Alpha | (0.20) | |||
| Sortino Ratio | (0) | |||
| Treynor Ratio | 0.0706 | |||
| Maximum Drawdown | 9.67 | |||
| Value At Risk | (3.61) | |||
| Potential Upside | 3.27 | |||
| Downside Variance | 5.29 | |||
| Semi Variance | 4.85 | |||
| Expected Short fall | (1.63) | |||
| Skewness | (0.07) | |||
| Kurtosis | 0.1841 |
Consider Core Laboratories' intraday indicators
Core Laboratories intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Core Laboratories stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Core Laboratories Corporate Filings
Core Laboratories time-series forecasting models is one of many Core Laboratories' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Core Laboratories' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.Core Stock media impact
Far too much social signal, news, headlines, and media speculation about Core Laboratories that are available to investors today. That information is available publicly through Core media outlets and privately through word of mouth or via Core internal channels. However, regardless of the origin, that massive amount of Core data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Core Laboratories news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Core Laboratories relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Core Laboratories' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Core Laboratories alpha.
Core Laboratories Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Core Laboratories can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Core Laboratories without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Global Markets Map Now
Global Markets MapGet a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |
| All Next | Launch Module |
Core Laboratories Corporate Directors
Core Laboratories corporate directors refer to members of a Core Laboratories board of directors. The board of directors generally takes responsibility for the Core Laboratories' affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Core Laboratories' board members must vote for the resolution. The Core Laboratories board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Charles Dunlap | Independent Member of the Board of Supervisory Directors | Profile | |
| Richard Bergmark | CFO, Executive VP and Supervisory Director | Profile | |
| Michael Kearney | Independent Supervisory Director | Profile | |
| Margaret Kempen | Independent Member of the Board of Supervisory Directors | Profile |
How to buy Core Stock?
To provide specific investment advice or recommendations on Core Laboratories NV stock, we recommend investors consider the following general factors when evaluating Core Laboratories NV. This will help you to make an informed decision on whether to include Core Laboratories in one of your diversified portfolios:- Examine Core Laboratories' financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Core Laboratories' leadership team and their track record. Good management can help Core Laboratories navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Oil & Gas Equipment & Services space and any emerging trends that could impact Core Laboratories' business and its evolving consumer preferences.
- Compare Core Laboratories' performance and market position to its competitors. Analyze how Core Laboratories is positioned in terms of product offerings, innovation, and market share.
- Check if Core Laboratories pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Core Laboratories' stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Core Laboratories NV stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Core Laboratories NV is a good investment.
Already Invested in Core Laboratories NV?
The danger of trading Core Laboratories NV is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Core Laboratories is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Core Laboratories. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Core Laboratories is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Core Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Core Laboratories' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Core Laboratories Nv Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Core Laboratories Nv Stock: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Core Laboratories NV. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Complementary Tools for Core Stock analysis
When running Core Laboratories' price analysis, check to measure Core Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Core Laboratories is operating at the current time. Most of Core Laboratories' value examination focuses on studying past and present price action to predict the probability of Core Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Core Laboratories' price. Additionally, you may evaluate how the addition of Core Laboratories to your portfolios can decrease your overall portfolio volatility.
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |
Is Core Laboratories' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Core Laboratories. If investors know Core will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Core Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.35 | Dividend Share 0.04 | Earnings Share 0.51 | Revenue Per Share 10.935 | Quarterly Revenue Growth 0.01 |
The market value of Core Laboratories is measured differently than its book value, which is the value of Core that is recorded on the company's balance sheet. Investors also form their own opinion of Core Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Core Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Core Laboratories' market value can be influenced by many factors that don't directly affect Core Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between Core Laboratories' value and its price, as these two are different measures arrived at by various means. Investors typically determine if Core Laboratories is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Core Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.